Sjögren's syndrome: When killers become helpers

Science Translational Medicine

Volumn 5, Issue 195, 2013, Pages

  Deshmukh, Umesh S ^a   Bagavant, Harini ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 H6 PROTEIN; CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CELLULAR IMMUNITY; DENDRITIC CELL; GENE LOCUS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NKP30 GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME;

EID: 84893465844     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006850     Document Type: Article

References (10)

1. N. P. Nikolov, G. G. Illei, Pathogenesis of Sjögren's syndrome. Curr. Opin. Rheumatol. 21, 465-470 (2009).
2. Y. Yao, Z. Liu, B. Jallal, N. Shen, L. Rönnblom, Type I interferons in Sjögren's syndrome. Autoimmun. Rev. 12, 558-566 (2013).
3. B. M. Szczerba, P. D. Rybakowska, P. Dey, K. M. Payerhin, A. B. Peck, H. Bagavant, U. S. Deshmukh, Type I interferon receptor deficiency prevents murine Sjogren's syndrome. J. Dent. Res. 92, 444-449 (2013).
4. E. O. Long, H. Sik Kim, D. Liu, M. E. Peterson, S. Rajagopalan, Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annu. Rev. Immunol. 31, 227-258 (2013).
5. S. Rusakiewicz, G. Nocturne, T. Lazure, M. Semeraro, C. Flament, S. Caillat-Zucman, D. Sène, N. Delahaye, E. Vivier, K. Chaba, V. Poirier-Colame, G. Nordmark, M.-L. Eloranta, P. Eriksson, E. Theander, H. Forsblad-d'Elia, R. Omdal, M. Wahren-Herlenius, R. Jonsson, L. Rönnblom, J. Nititham, K. E. Taylor, C. J. Lessard, K. L. Moser Sivils, J.-E. Gottenberg, L. A. Criswell, C. Miceli-Richard, L. Zitvogel, X. Mariette, NCR3/NKp30 contributes to pathogenesis in primary Sjögren's syndrome. Sci. Trans. Med. 5, 195ra96 (2013).
6. Z. Tian, M. E. Gershwin, C. Zhang, Regulatory NK cells in autoimmune disease. J. Autoimmun. 39, 206-215 (2012).
7. P. Szodoray, G. Papp, I. F. Horvath, S. Barath, S. Sipka, B. Nakken, M. Zeher, Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome. Clin. Exp. Immunol. 157, 343-349 (2009).
8. Y. Izumi, H. Ida, M. Huang, N. Iwanaga, F. Tanaka, K. Aratake, K. Arima, M. Tamai, M. Kamachi, H. Nakamura, T. Origuchi, A. Kawakami, P. Anderson, K. Eguchi, Characterization of peripheral natural killer cells in primary Sjögren's syndrome: Impaired NK cell activity and low NK cell number. J. Lab. Clin. Med. 147, 242-249 (2006).
9. T. Kaifu, B. Escalière, L. N. Gastinel, E. Vivier, M. Baratin, B7- H6/NKp30 interaction: A mechanism of alerting NK cells against tumors. Cell. Mol. Life Sci. 68, 3531-3539 (2011).
10. S. R. Nandula, Y. M. Scindia, P. Dey, H. Bagavant, U. S. Deshmukh, Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndromelike disease. Oral Dis. 17, 801-807 (2011).